Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 10
2015 4
2016 13
2017 7
2018 6
2019 4
2020 6
2021 4
2022 5
2023 6
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Waldenström Macroglobulinemia: Review of Pathogenesis and Management.
Yun S, Johnson AC, Okolo ON, Arnold SJ, McBride A, Zhang L, Baz RC, Anwer F. Yun S, et al. Clin Lymphoma Myeloma Leuk. 2017 May;17(5):252-262. doi: 10.1016/j.clml.2017.02.028. Epub 2017 Mar 7. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28366781 Free PMC article. Review.
Clinicopathologic characteristics, genetic features, and treatment options for acute lymphoblastic leukemia with JAK2 rearrangement-A 10-case study and literature review.
Zhang L, Shah B, Zhang Y, Tashkandi H, Xiao W, Fernandez-Pol S, Vergara-Lluri M, Hussaini M, Song J, Lancet J, Moscinski L, Yun S, Lu CM, Medeiros LJ, Tang G. Zhang L, et al. Among authors: yun s. Hum Pathol. 2023 Jun;136:1-15. doi: 10.1016/j.humpath.2023.03.002. Epub 2023 Mar 22. Hum Pathol. 2023. PMID: 36958463 Review.
Response to Katona et al.
Oh M, McBride A, Yun S, Bhattacharjee S, Slack M, Martin JR, Jeter J, Abraham I. Oh M, et al. Among authors: yun s. J Natl Cancer Inst. 2019 May 1;111(5):524-525. doi: 10.1093/jnci/djz013. J Natl Cancer Inst. 2019. PMID: 30715401 No abstract available.
Integrative molecular subtypes of acute myeloid leukemia.
Mo Q, Yun S, Sallman DA, Vincelette ND, Peng G, Zhang L, Lancet JE, Padron E. Mo Q, et al. Among authors: yun s. Blood Cancer J. 2023 May 8;13(1):71. doi: 10.1038/s41408-023-00836-4. Blood Cancer J. 2023. PMID: 37156780 Free PMC article. No abstract available.
Brentuximab vedotin for treatment of non-Hodgkin lymphomas: A systematic review.
Berger GK, McBride A, Lawson S, Royball K, Yun S, Gee K, Bin Riaz I, Saleh AA, Puvvada S, Anwer F. Berger GK, et al. Among authors: yun s. Crit Rev Oncol Hematol. 2017 Jan;109:42-50. doi: 10.1016/j.critrevonc.2016.11.009. Epub 2016 Nov 21. Crit Rev Oncol Hematol. 2017. PMID: 28010897 Free PMC article. Review.
Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk NPM1-mutated AML.
Chan O, Al Ali N, Tashkandi H, Ellis A, Ball S, Grenet J, Hana C, Deutsch Y, Zhang L, Hussaini M, Song J, Yun S, Talati C, Kuykendall A, Padron E, Walker A, Roboz G, Desai P, Sallman D, Sweet K, Komrokji R, Lancet J. Chan O, et al. Among authors: yun s. Blood Adv. 2024 Mar 12;8(5):1075-1083. doi: 10.1182/bloodadvances.2023011173. Blood Adv. 2024. PMID: 38170740 Free PMC article.
64 results